Insulin-like growth factor-I modulates monocyte adhesion to EAhy 926 endothelial cells.
IGF-I is a ubiquitous growth factor, found in platelets and elaborated by many other cell types. It is thought to be involved in several pathophysiological processes including embryonic development, angiogenesis and wound healing. We report that the adherence of human peripheral blood monocytes to an endothelial cell line (EAhy 926) is inhibited in a dose and time-dependent manner by pre-incubating the endothelial cells with IGF-I (P < 0.001). Monocyte adhesion was inhibited 17.9 +/- 1.9% by IGF-I at a dose of 1000 ng/ml (P < 0.01). In contrast, IGF-I had no significant effect on monocyte adherence to plastic. The inhibitory effects of IGF-I were reversed by co-incubating the endothelial cells with the nitric oxide synthase inhibitor, L-NAME. These data suggest that the effects of IGF-I are mediated by the release of nitric oxide from the endothelial cells.
Motani
A
A
William Harvey Research Institute, London, UK.
Forster
L
L
Tull
S
S
Anggård
E E
EE
Ferns
G A
GA
D000328:Adult; D000368:Aged; D002448:Cell Adhesion / Q000187:drug effects; D018929:Cell Culture Techniques; D002460:Cell Line; D004305:Dose-Response Relationship, Drug; D004727:Endothelium / Q000166:cytology; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000494:pharmacology*; D008875:Middle Aged; D009000:Monocytes / Q000187:drug effects* / Q000201:enzymology / Q000502:physiology; D009569:Nitric Oxide / Q000502:physiology; D009195:Peroxidase / Q000097:blood; D013997:Time Factors
D009569:Nitric Oxide; D007334:Insulin-Like Growth Factor I; D009195:Peroxidase